The final, formatted version of the article will be published soon. Abstract: Introduction: Advances in endoscopic techniques have revolutionized gastrointestinal therapy, offering reduced morbidity ...

OverStitch has new indications for use statement under CE-Mark, including indications for defect closure, stent fixation, endoscopic sleeve gastroplasty and transoral outlet reduction AUSTIN, TX / ...

For the first time in Canada, doctors at Vancouver General Hospital successfully sutured a patient using a new Overstitch device. “It’s very important,” Dr. Roberto Trasolini, a therapeutic ...

Introduction Obesity is an increasing health problem worldwide. Roux-en-Y gastric bypass can produce a 56%–66% wt loss 2 years after surgery. Roughly 20% of patients fail to achieve 50% wt loss in the ...

AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that ...

Introduction The Apollo OverStitch is a minimally invasive endoscopic suturing device which allows full thickness suturing without the need for surgery Roux-en-Y gastric bypass (RYGB) can achieve up ...

Austin, TX /PRNewswire/ - Apollo Endosurgery, Inc. announced that their newly-launched OverStitch™ Endoscopic Suturing System has recently been employed in several, first-in-human cases. OverStitch ...

AUSTIN, Texas--(BUSINESS WIRE)-- Apollo Endosurgery (“Apollo”) (NASDAQ:APEN), a leader in less invasive surgical medical devices for bariatric and gastrointestinal procedures, announced today U.S.

Apollo Endosurgery, Inc. announced today the first commercial shipments of the OverStitch™ Sx Endoscopic Suturing System. These initial customer shipments launch the first phase of the global product ...

AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a leader in less invasive surgical medical devices for bariatric and gastrointestinal procedures, announced today U.S ...

OverStitch has new indications for use statement under CE-Mark, including indications for defect closure, stent fixation, endoscopic sleeve gastroplasty and transoral outlet reduction AUSTIN, TX / ...